EU regulator warns of shortage in Baxter's cancer treatment until early 2027

EU regulator warns of shortage in Baxter's cancer treatment until early 2027 | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv A European Union flag flutters outside the European Commission headquarters in Brussels, Belgium Februrary 26, 2026. REUTERS/Yves Herman/File Photo Purchase Licensing Rights, opens new tab The European Medicines Agency said the shortage was due to a technical disruption at Baxter's contract manufacturing sit ...